MedTrace Logo

Effect of Fermented Soy Based Product on Cardiometabolic Risk Factors

NCT03429920 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 28

Last updated 2021-02-04

No results posted yet for this study

Summary

This research study will test the effects of Q CAN PLUS powder on serum lipids, selected inflammatory and oxidative parameters and genome-wide methylation

Conditions

Interventions

DIETARY_SUPPLEMENT

Q CAN PLUS

Active powder with fermented soy , 2 pouches per day, each pouch contains 12-15 gms of fermented soy

DIETARY_SUPPLEMENT

Placebo

Sprouted brown rice protein with flavor (provided by BESO Biological Research, Inc.)

Sponsors & Collaborators

  • Loma Linda University

    lead OTHER

Principal Investigators

  • Joan Sabate, DrPH · Loma Linda University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
29 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-09-23
Primary Completion
2019-08-01
Completion
2019-08-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03429920 on ClinicalTrials.gov